The global respiratory care market is estimated to be valued at USD 25.95 Bn in 2024 and is expected to exhibit a CAGR of 9.8% during the forecast period (2024-2031). The global respiratory care market is witnessing a phase of robust growth due to the increasing prevalence of respiratory diseases globally. Rising air pollution levels, growing geriatric population, and the high number of smokers are some of the key factors contributing to the rising caseload of respiratory illnesses. Moreover, technological advancements in respiratory care devices along with high demand for home care therapeutic devices are augmenting the market expansion. The lack of awareness about respiratory diseases in developing nations and high cost of innovative devices may impede the market growth. Overall, improved access to care, new product introductions, and increasing healthcare expenditures are projected to present lucrative prospects for respiratory care devices over the forecast period.
Market Dynamics:
The global respiratory care market is driven by factors such as the increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, rapidly growing geriatric population, technological advancements in devices, and high demand for portable & home care therapeutic devices. However, the market growth can be restrained due to the high cost of innovative devices and lack of awareness about respiratory diseases in developing nations. Major opportunities in the market include untapped potential of emerging economies, growing adoption of e-business models, and increasing access to healthcare facilities & care providers globally.
Key Features of the Study:
- This report provides an in-depth analysis of the global respiratory care market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global respiratory care market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes Koninklijke Philips N.V., ICU Medical, Inc., Teleflex Incorporated, ResMed, Dragerwerk AG & Co. KGaA, Belluscura, VYAIRE, Medline Industries, OMRON Corporation, Xplore Health Technologies Pvt. Ltd., Masimo, Fisher & Paykel Healthcare Limited, Hamilton Medical, TytoCare Ltd., Inogen, Inc., Honeywell International Inc., and PARI Pharma GmbH
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global respiratory care market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory care market
Detailed Segmentation-
- Product Type:
-
- Nebulizers
- Oxygen Concentrators
- Polysomnography Devices
- Positive airway pressure devices
- Respiratory Consumables
- Others
- Indication:
-
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Pneumonia
- Others
- End User:
-
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
- Region:
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
-
- Medtronic
- Koninklijke Philips N.V.
- ICU Medical, Inc.
- Teleflex Incorporated
- ResMed
- Dragerwerk AG & Co. KGaA
- Belluscura
- VYAIRE
- Medline Industries
- OMRON Corporation
- Xplore Health Technologies Pvt. Ltd.
- Masimo
- Fisher & Paykel Healthcare Limited
- Hamilton Medical
- TytoCare Ltd.
- Inogen, Inc.
- Honeywell International Inc.
- PARI Pharma GmbH